CAIHF (CPBIO Holding Co) Short-Term Debt: $54.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAIHF CPBIO Holding Co Ltd CAIHF
58 GF Score
Price $1.07
GF Value $0.16
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is CPBIO Holding Co Short-Term Debt?

CPBIO Holding Co CAIHF 58 Short-Term Debt is $54.8 Mil as of Mar. 2026. GuruFocus rates CAIHF with a GF Score™ of 58/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 5 warning signs investors should review.

CPBIO Holding Co's Short-Term Debt for the quarter that ended in Mar. 2026 was $54.8 Mil.

CPBIO Holding Co's quarterly Short-Term Debt declined from Sep. 2025 ($46.7 Mil) to Dec. 2025 ($38.7 Mil) but then increased from Dec. 2025 ($38.7 Mil) to Mar. 2026 ($54.8 Mil).

CPBIO Holding Co's annual Short-Term Debt declined from Dec. 2023 ($58.1 Mil) to Dec. 2024 ($57.3 Mil) and declined from Dec. 2024 ($57.3 Mil) to Dec. 2025 ($38.7 Mil).

CPBIO Holding Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

CPBIO Holding Co Short-Term Debt Related Terms

CPBIO Holding Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for CPBIO Holding Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CPBIO Holding Co Short-Term Debt Chart

CPBIO Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.33 36.84 58.12 57.29 38.73

CPBIO Holding Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.84 46.71 38.73 54.76 65.07
CAIHF
58GF Score
CPBIO Holding Co Ltd CAIHF
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $54.8 Mil mean?
CPBIO Holding Co (CAIHF) has a Short-Term Debt of $54.8 Mil as of Mar. 2026.
Is CPBIO Holding Co's Short-Term Debt too high?
CPBIO Holding Co's current Short-Term Debt is $54.8 Mil. Overall, CPBIO Holding Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CPBIO Holding Co's Short-Term Debt compare to ZTS?
CPBIO Holding Co's Short-Term Debt of $54.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. CPBIO Holding Co's current Short-Term Debt is $54.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CPBIO Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CPBIO Holding Co (CAIHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $1.07 — trading 567.3% above its estimated fair value. The current Short-Term Debt is $54.8 Mil. CPBIO Holding Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For CPBIO Holding Co (CAIHF), the current Short-Term Debt is $54.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CPBIO Holding Co (CAIHF) Overvalued in 2026?

Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued. The current stock price of $1.07 is trading 567.3% above its estimated GF Value™ of $0.16. GuruFocus considers CPBIO Holding Co to be Significantly Overvalued.

Key valuation signals for CAIHF:

  • Short-Term Debt: $54.8 Mil
  • GF Value™: $0.16 vs. price of $1.07 (567.3% above fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the CAIHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CPBIO Holding Co Business Description

Other Exchanges 03839:Hong Kong
Address 16 Harcourt Road, 21st Floor, Far East Finance Centre, Central, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
58GF Score

Get the complete analysis for CAIHF

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$0.16
GF Value